Genex Pharmaceutical Inc
Genex Pharmaceutical, Inc. produces and distributes Reconstituted Bone Xenograft (RBX) in the People's Republic of China. The RBX is a medical device that accelerates bone healing. The company distributes its medical devices to approximately 500 hospitals, as well as to other medical device customers. Genex Pharmaceutical, Inc. was founded in 2003 and is headquartered in Tianjin, the People's Rep… Read more
Genex Pharmaceutical Inc (GENX) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of December 2007: 0.001x
Based on the latest financial reports, Genex Pharmaceutical Inc (GENX) has a cash flow conversion efficiency ratio of 0.001x as of December 2007.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($5.41K) by net assets ($4.74 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Genex Pharmaceutical Inc - Cash Flow Conversion Efficiency Trend (2003–2007)
This chart illustrates how Genex Pharmaceutical Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Genex Pharmaceutical Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Genex Pharmaceutical Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Protek Capital Inc.
PINK:PRPM
|
-0.259x |
|
Media Way Corp
PINK:MDAW
|
0.428x |
|
Nexis International Industries Inc
PINK:NXSI
|
0.073x |
|
SES Solar Inc
PINK:SESI
|
0.158x |
|
Nextmart Inc
PINK:NXMR
|
-0.254x |
|
Kidville Inc
PINK:KVIL
|
-0.328x |
|
Terme Bancorp Inc
PINK:TMEB
|
226.194x |
|
NeoMedia Technologies Inc
PINK:NEOM
|
0.000x |
Annual Cash Flow Conversion Efficiency for Genex Pharmaceutical Inc (2003–2007)
The table below shows the annual cash flow conversion efficiency of Genex Pharmaceutical Inc from 2003 to 2007.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2007-12-31 | $4.74 Million | $529.66K | 0.112x | -61.50% |
| 2006-12-31 | $4.07 Million | $1.18 Million | 0.290x | -30.12% |
| 2005-12-31 | $3.32 Million | $1.38 Million | 0.415x | +1105.18% |
| 2004-12-31 | $2.61 Million | $90.05K | 0.034x | +101.08% |
| 2003-12-31 | $13.06K | $-41.71K | -3.194x | -- |